CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Enveda raises its third megaround for I&I and weight maintenance drug candidates

Positive
AI Analysis

Summary

Enveda, a Colorado and India-based biotech startup focused on plant and microbe chemistry, raised $311 million in its third major funding round for inflammation & infection and weight maintenance drug candidates.

Importance:5/10
Sentiment:
0.60
fundingSeries Ccapital raiseinflammationweight management
Related Companies

Read the original article

Published by Endpoints News on September 23, 2026 3:21 PM

Read Original